185 related articles for article (PubMed ID: 24923906)
1. Macrophagic myofasciitis and vaccination: consequence or coincidence?
Santiago T; Rebelo O; Negrão L; Matos A
Rheumatol Int; 2015 Jan; 35(1):189-92. PubMed ID: 24923906
[TBL] [Abstract][Full Text] [Related]
2. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
Gherardi RK; Coquet M; Cherin P; Belec L; Moretto P; Dreyfus PA; Pellissier JF; Chariot P; Authier FJ
Brain; 2001 Sep; 124(Pt 9):1821-31. PubMed ID: 11522584
[TBL] [Abstract][Full Text] [Related]
3. Macrophagic myofasciitis: a summary of Dr. Gherardi's presentations.
Brenner A
Vaccine; 2002 May; 20 Suppl 3():S5-6. PubMed ID: 12184366
[TBL] [Abstract][Full Text] [Related]
4. Polyglandular autoimmunity with macrophagic myofasciitis.
Theeler BJ; Simper NB; Ney JP
Clin Rheumatol; 2008 May; 27(5):667-9. PubMed ID: 18180978
[TBL] [Abstract][Full Text] [Related]
5. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system.
Gherardi RK; Crépeaux G; Authier FJ
Autoimmun Rev; 2019 Jul; 18(7):691-705. PubMed ID: 31059838
[TBL] [Abstract][Full Text] [Related]
6. Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.
Chkheidze R; Burns DK; White CL; Castro D; Fuller J; Cai C
J Neuropathol Exp Neurol; 2017 Apr; 76(4):323-331. PubMed ID: 28340105
[TBL] [Abstract][Full Text] [Related]
7. Macrophagic myofasciitis in children is a localized reaction to vaccination.
Lach B; Cupler EJ
J Child Neurol; 2008 Jun; 23(6):614-9. PubMed ID: 18281624
[TBL] [Abstract][Full Text] [Related]
8. Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.
Kim H; Lim KY; Kang J; Park JW; Park SH
Sci Rep; 2020 Jul; 10(1):11834. PubMed ID: 32678281
[TBL] [Abstract][Full Text] [Related]
9. Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: an exploratory study.
Ragunathan-Thangarajah N; Le Beller C; Boutouyrie P; Bassez G; Gherardi RK; Laurent S; Authier FJ
J Inorg Biochem; 2013 Nov; 128():262-6. PubMed ID: 23921285
[TBL] [Abstract][Full Text] [Related]
10. [Macrophagic myofasciitis: inflammatory, vaccination-associated muscular disease].
Fischer D; Reimann J; Schröder R
Dtsch Med Wochenschr; 2003 Oct; 128(44):2305-8. PubMed ID: 14593574
[TBL] [Abstract][Full Text] [Related]
11. Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease.
Gherardi RK; Aouizerate J; Cadusseau J; Yara S; Authier FJ
Morphologie; 2016 Jun; 100(329):85-94. PubMed ID: 26948677
[TBL] [Abstract][Full Text] [Related]
12. [Vaccine adjuvants and macrophagic myofasciitis].
Siegrist CA
Bull Acad Natl Med; 2003; 187(8):1511-8; discussion 1519-21. PubMed ID: 15146582
[TBL] [Abstract][Full Text] [Related]
13. Macrophagic myofasciitis in childhood: a controversial entity.
Rivas E; Gómez-Arnáiz M; Ricoy JR; Mateos F; Simón R; García-Peñas JJ; Garcia-Silva MT; Martín E; Vázquez M; Ferreiro A; Cabello A
Pediatr Neurol; 2005 Nov; 33(5):350-6. PubMed ID: 16243223
[TBL] [Abstract][Full Text] [Related]
14. Aluminum phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis.
Lacson AG; D'Cruz CA; Gilbert-Barness E; Sharer L; Jacinto S; Cuenca R
Pediatr Dev Pathol; 2002; 5(2):151-8. PubMed ID: 11910509
[TBL] [Abstract][Full Text] [Related]
15. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].
Gherardi RK
Rev Neurol (Paris); 2003 Feb; 159(2):162-4. PubMed ID: 12660567
[TBL] [Abstract][Full Text] [Related]
16. Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease.
Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
Clin Rev Allergy Immunol; 2011 Oct; 41(2):163-8. PubMed ID: 20882368
[TBL] [Abstract][Full Text] [Related]
17. Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants?
Guis S; Mattei JP; Nicoli F; Pellissier JF; Kaplanski G; Figarella-Branger D; Manez GC; Antipoff GM; Roudier J
Arthritis Rheum; 2002 Oct; 47(5):543-5. PubMed ID: 12382305
[No Abstract] [Full Text] [Related]
18. Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA.
Cadusseau J; Ragunathan-Thangarajah N; Surenaud M; Hue S; Authier FJ; Gherardi RK
Curr Med Chem; 2014; 21(4):511-7. PubMed ID: 24083602
[TBL] [Abstract][Full Text] [Related]
19. Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine-induced adverse events.
Matsumura N; Shiro R; Tsunoda I
Cancer Sci; 2023 Apr; 114(4):1218-1228. PubMed ID: 36601818
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF).
Passeri E; Villa C; Couette M; Itti E; Brugieres P; Cesaro P; Gherardi RK; Bachoud-Levi AC; Authier FJ
J Inorg Biochem; 2011 Nov; 105(11):1457-63. PubMed ID: 22099155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
